[HTML][HTML] EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood

M Weller, M van den Bent, M Preusser… - Nature reviews Clinical …, 2021 - nature.com
In response to major changes in diagnostic algorithms and the publication of mature results
from various large clinical trials, the European Association of Neuro-Oncology (EANO) …

Glioblastoma: clinical presentation, diagnosis, and management

C McKinnon, M Nandhabalan, SA Murray, P Plaha - Bmj, 2021 - bmj.com
• Early symptoms of brain tumours in adults are non-specific, and patients may present
multiple times to primary care services before they are referred for investigation. Look for …

Primary brain tumours in adults

MJ van den Bent, M Geurts, PJ French, M Smits… - The Lancet, 2023 - thelancet.com
The most frequent adult-type primary CNS tumours are diffuse gliomas, but a large variety of
rarer CNS tumour types exists. The classification of these tumours is increasingly based on …

Longer-term (≥ 2 years) survival in patients with glioblastoma in population-based studies pre-and post-2005: a systematic review and meta-analysis

MTC Poon, CLM Sudlow, JD Figueroa, PM Brennan - Scientific reports, 2020 - nature.com
Translation of survival benefits observed in glioblastoma clinical trials to populations and to
longer-term survival remains uncertain. We aimed to assess if≥ 2-year survival has …

Ferroptosis-related gene signature predicts glioma cell death and glioma patient progression

H Liu, H Hu, G Li, Y Zhang, F Wu, X Liu… - Frontiers in cell and …, 2020 - frontiersin.org
Glioma is a fatal brain tumor characterized by rapid proliferation and treatment resistance.
Ferroptosis is a newly discovered programmed cell death and plays a crucial role in the …

Trends in intracranial glioma incidence and mortality in the United States, 1975-2018

D Lin, M Wang, Y Chen, J Gong, L Chen, X Shi… - Frontiers in …, 2021 - frontiersin.org
Purpose Glioma incidence in the US seems to have stabilized over the past 20 years. It's
also not clear whether changes in glioblastoma incidence are associated with glioma …

Prevalence of symptoms in glioma patients throughout the disease trajectory: a systematic review

M IJzerman-Korevaar, TJ Snijders, A de Graeff… - Journal of neuro …, 2018 - Springer
Background Glioma patients suffer from a wide range of symptoms which influence quality of
life negatively. The aim of this review is to give an overview of symptoms most prevalent in …

The global prevalence of primary central nervous system tumors: a systematic review and meta-analysis

N Salari, H Ghasemi, R Fatahian, K Mansouri… - European journal of …, 2023 - Springer
Background Primary central nervous system (CNS) tumors are a heterogeneous group of
neoplasms, including benign and malignant tumors. Since there are many heterogeneities …

Establishment of age group classification for risk stratification in glioma patients

Z Lin, R Yang, K Li, G Yi, Z Li, J Guo, Z Zhang… - BMC neurology, 2020 - Springer
Background Age is associated with the prognosis of glioma patients, but there is no uniform
standard of age-group classification to evaluate the prognosis of glioma patients. In this …

Ferroptosis and its potential role in the nervous system diseases

Y Zhou, W Lin, T Rao, J Zheng, T Zhang… - Journal of …, 2022 - Taylor & Francis
Ferroptosis is a novel regulated cell death characterized by metabolic disorders and iron-
dependent oxidative destruction of the lipid bilayer. It is primarily caused by the imbalance of …